Related Experiment Video
Updated: May 4, 2026
06:39
Real-Time Void Spot Assay
Published on: February 10, 2023
2.7K
Nocturia and overactive bladder in obese women: A case-control study
Ingela Melin1, Christian Falconer1, Stephan Rössner1
1Department of Medical Epidemiology and Biostatistics Karolinska Institutet, Sweden.
Obesity Research & Clinical Practice
|December 20, 2013
Summary
Obese women experience significantly more nocturia (waking to urinate) and overactive bladder symptoms compared to non-obese women. These findings highlight the increased risk of urinary issues associated with obesity.
Area of Science:
- Urology
- Obesity Medicine
- Public Health
Background:
- Obesity is a growing global health concern.
- Lower urinary tract symptoms (LUTS) and nocturia can significantly impact quality of life.
Purpose of the Study:
- To determine the prevalence and severity of nocturia and LUTS in obese women.
- To identify risk factors for nocturia in this population.
Main Methods:
- A case-control study was conducted using data from a university hospital obesity unit.
- Obese women (BMI ≥30) were matched with non-obese controls.
- Data were collected via self-reported postal surveys.
Main Results:
- Obese women reported significantly higher prevalence and bother of nocturia, frequent urination, and bothersome urination.
- Increased urinary urgency, urge urinary incontinence, and bladder emptying difficulties were observed in obese women.
- Adjusted odds ratios indicated substantially higher risks for nocturia, frequent urination, strong urge to void, and urgency-related incontinence in obese women.
Conclusions:
- Obesity is associated with a substantially increased risk of nocturia.
- Obese women face a significantly higher risk of developing overactive bladder symptoms.
Related Concept Videos
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
860
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
860
01:23Urinary Bladder
4.7K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
4.7K
01:21Nursing Assessment of the Genitourinary System I: Health History
822
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
822
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
01:21Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368